🔴 Sionna Therapeutics is trading 5% down on October 22, 2026, amid broader market weakness

Sionna Therapeutics is trading at $3.66, down 5.43%, amid broad market weakness; no company-specific catalyst was identified.

• No company-specific announcement was identified on October 22; its latest listed release was October 8, covering conference data.
• The Nasdaq was down 2.50% and the S&P 500 was down 1.37%. Reports cited risk-off pressure amid AI-spending concerns and renewed Strait of Hormuz tensions that pushed oil higher. This backdrop may have contributed, but no direct Sionna-specific cause was identified.